ECM
XGN icon

ExodusPoint Capital Management’s Exagen XGN Stock Holding History

ExodusPoint Capital Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,321
Closed -$239K – 2162
2025
Q4 		$239K Buy
39,321
+29,037
+282% +$264K ﹤0.01% 1360
2025
Q3 		$113K Buy
+10,284
New +$91.1K ﹤0.01% 1421

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

ExodusPoint Capital Management's XGN Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Exagen (XGN) in Q1 2026, closing a stake of 39,321 shares — an estimated $239K sold.

ExodusPoint Capital Management first reported a position in XGN in Q3 2025 and held it in 2 quarters. The position peaked at $239K in Q4 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 39,321 Exagen shares in Q1 2026, an estimated $239K.
  • ExodusPoint Capital Management first reported a position in Exagen in Q3 2025 and held it in 2 quarters.
  • ExodusPoint Capital Management's Exagen position peaked at $239K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.